| || |
|Bifidobacterium Pseudocatenulatum Associated With Atopic Eczema|
NEW YORK (Reuters Health) Feb 13 - Bifidobacterium pseudocatenulatum, commonly found in the fecal microflora of infants, is associated with atopic eczema and is also more prevalent in infants who are not breast fed.
B. pseudocatenulatum may therefore be a biomarker for susceptibility to this atopic disease, Dr. Gerald W. Tannock, of the University of Otago, Dunedin, New Zealand, and colleagues report.
In a nested case-control study, the researchers compared fecal bacterial communities of 37 infants with and 24 infants without eczema. The team matched the infants, who were 3 to 6 months of age, for sex, age, feeding method, weaning, and ethnicity. They also collected information on maternal and infant antibiotic exposure, feeding, gastrointestinal symptoms, and family history of allergy.
No significant differences in overall profiles of fecal bacterial communities were observed between cases and controls. Infants with a family history of allergic disease were significantly more likely to have bifidobacteria
in their feces than those without a family history
An association was observed between non-breast-feeding and the presence of B. pseudocatenulatum.
The increased risk was confirmed in logistic regression analysis
B. pseudocatenulatum was also detected more commonly in children with eczema than in those without eczema , according to the report in the January issue of the Journal of Allergy and Clinical Immunology.
"Clinical measurements did not reveal an association between B. pseudocatenulatum and specific factors of importance in allergic diseases," Dr. Tannock's team notes. "Therefore, we cannot propose an etiologic role for this bacterial species in atopic eczema."
"Nonetheless, the association of these bacteria with an atopic condition fits well with previous observations that we have made in relation to bifidobacteria and allergic diseases of children."
Introduction to Bifidobacterium
. Protection against enteric pathogens, immune system activation and vitamin production, are some of the the benefic properties, attributed to the members of the Bifidobacterium genus. Also, mechanisms involved with reduction of cholesterol levels and antitumoral activity, have been proposed
One of the useful lactic acid producing bacteria which are found in many probiotics and are essential for health
Natural colonizers of the human intestinal tract1 - this makes them a highly desirable probiotic
Long history of being consumed by people with complete safety
They are the FIRST beneficial bacteria to colonize a babies gastrointestinal tract after birth - got to think mother nature's trying to tell us something there!
Although discovered back in 1899 they have been grouped in with Lactobacillus for much of this time due to their similarities.
Although Bifidobacteria make up only 3 to 6% of the bacteria count in adult stools, their presence has been associated with many beneficial health effects such as the prevention of diarrhea, the reduction of lactose intolerance, an immune enhancement1.
When you examine the number of problems where a lowered number of Bifidobacteria in the colon is known to occur - diarrhea, Crohn' disease, Inflammatory Bowel disease (IBD) -you can see just why this probiotic is of such importance to human health.
They assist with both vitamin and protein synthesis, assist in digestion and absorption, prevent colonization of bad bacteria, and stimulate the immune response. 3
Some strains of this bacteria have been successful in either treating or helping with necrotizing enterocolitis (in infants), diarrhea in infants, traveler's diarrhea, atopic eczema, IBS, pouchitis, Helicobacter pylori and ulcerative colitis
The first milk is calledcolostrum and is yellow in colour and quite rich but small in amount. For this reason it is usual for babies to lose up to 10 % of their birthweight. The main milk supply will not come in until about the 3rd day postnatal. In those first days before your milk is established your baby may feed every two to four hours
Please continue to information on EMG/NCV next page work in progress on this link